Nature's Sunshine Products, Inc.
$19.90
-4.3%Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
High confidenceValuation multiple is mid-range (P/E 18.4).
Valuation inputs: P/E 18.4, earnings yield +5.4%, momentum -4.3%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is acceptable (ROE +12.1%, ROIC +9.1%).
Profitability stack: net margin +4.1%, ROE +12.1%, ROIC +9.1%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +38.1%, momentum -4.3%, net margin +4.1%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Nature's Sunshine Products, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Nature's Sunshine Products, Inc. Fair Value Envelope
Nature's Sunshine Products, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
Nature's Sunshine Products, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Nature's Sunshine Products, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
Nature's Sunshine Products, Inc. Street Expectations Map
Wall Street analysts project that NATR stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 37.00, with estimates ranging from a low of 37.00 to a high of 37.00.
The consensus 1-year price target stands at 37.00, with estimates ranging from a low of 37.00 to a high of 37.00.
Analyst Consensus Analysis
Upside Potential
Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.
Analyst Agreement
High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.
Analyst Conviction
Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.
Market Sentiment Insight
Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.
Nature's Sunshine Products, Inc. Insider Positioning
During the last 12 months, insiders have sold $35.05M worth of NATR shares, with no buying activity reported.
3 Months
0
0.00
50.9K
1.21M
-1.2M
-$1.21M
3-6 Months
0
0.00
1.7K
37.89K
-38K
-$38K
6-9 Months
0
0.00
18.9K
383.13K
-383K
-$383K
9-12 Months
0
0.00
2.9M
33.41M
-33.4M
-$33.41M
Top Buyers
No buying activity
Top Sellers
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10 Percent Owner
$32.71M
Yates Bryant J
Officer: Evp & President, Europe
$701K
Norman Daniel C
Officer: Evp & President, Asia
$584K
Brower Nathan G
Officer: Evp, General Counsel
$529K
Lanoy Jonathan David
Officer: Svp, Chief Accounting Officer
$289K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $35.05M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
natr Dividend History
Learning Layer
Related Guides
Build conviction on NATR by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.